220 related articles for article (PubMed ID: 32748031)
1. LMDS-1, a potential TrkB receptor agonist provides a safe and neurotrophic effect for early-phase Alzheimer's disease.
Fan CH; Lin CW; Huang HJ; Lee-Chen GJ; Sun YC; Lin W; Chen CM; Chang KH; Su MT; Hsieh-Li HM
Psychopharmacology (Berl); 2020 Oct; 237(10):3173-3190. PubMed ID: 32748031
[TBL] [Abstract][Full Text] [Related]
2. Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity.
Chiu YJ; Lin TH; Chang KH; Lin W; Hsieh-Li HM; Su MT; Chen CM; Sun YC; Lee-Chen GJ
Aging (Albany NY); 2022 Sep; 14(18):7568-7586. PubMed ID: 36170028
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer's disease.
Aytan N; Choi JK; Carreras I; Crabtree L; Nguyen B; Lehar M; Blusztajn JK; Jenkins BG; Dedeoglu A
Eur J Pharmacol; 2018 Jun; 828():9-17. PubMed ID: 29510124
[TBL] [Abstract][Full Text] [Related]
4. The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice.
Li N; Liu GT
Acta Pharmacol Sin; 2010 Mar; 31(3):265-72. PubMed ID: 20154710
[TBL] [Abstract][Full Text] [Related]
5. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
Devi L; Ohno M
Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
[TBL] [Abstract][Full Text] [Related]
6. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease.
Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y
J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Action of Coumarin Derivatives through Activation of TRKB-CREB-BDNF Pathway and Reduction of Caspase Activity in Neuronal Cells Expressing Pro-Aggregated Tau Protein.
Lin TH; Chang KH; Chiu YJ; Weng ZK; Sun YC; Lin W; Lee-Chen GJ; Chen CM
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361524
[TBL] [Abstract][Full Text] [Related]
8. Harpagoside ameliorates the amyloid-β-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK/PI3K pathways.
Li J; Ding X; Zhang R; Jiang W; Sun X; Xia Z; Wang X; Wu E; Zhang Y; Hu Y
Neuroscience; 2015 Sep; 303():103-14. PubMed ID: 26135675
[TBL] [Abstract][Full Text] [Related]
9. Donepezil improves the cognitive impairment in a tree shrew model of Alzheimer's disease induced by amyloid-β
Zheng H; Niu S; Zhao H; Li S; Jiao J
Metab Brain Dis; 2018 Dec; 33(6):1961-1974. PubMed ID: 30105614
[TBL] [Abstract][Full Text] [Related]
10. Blocking GSK3β-mediated dynamin1 phosphorylation enhances BDNF-dependent TrkB endocytosis and the protective effects of BDNF in neuronal and mouse models of Alzheimer's disease.
Liu XH; Geng Z; Yan J; Li T; Chen Q; Zhang QY; Chen ZY
Neurobiol Dis; 2015 Feb; 74():377-91. PubMed ID: 25484286
[TBL] [Abstract][Full Text] [Related]
11. Neurogenic and neurotrophic effects of BDNF peptides in mouse hippocampal primary neuronal cell cultures.
Cardenas-Aguayo Mdel C; Kazim SF; Grundke-Iqbal I; Iqbal K
PLoS One; 2013; 8(1):e53596. PubMed ID: 23320097
[TBL] [Abstract][Full Text] [Related]
12. Icariside II, a Phosphodiesterase-5 Inhibitor, Attenuates Beta-Amyloid-Induced Cognitive Deficits via BDNF/TrkB/CREB Signaling.
Liu S; Li X; Gao J; Liu Y; Shi J; Gong Q
Cell Physiol Biochem; 2018; 49(3):985. PubMed ID: 30196289
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease.
Wang S; Yao H; Xu Y; Hao R; Zhang W; Liu H; Huang Y; Guo W; Lu B
Theranostics; 2020; 10(15):6854-6874. PubMed ID: 32550908
[TBL] [Abstract][Full Text] [Related]
14. 7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways.
Tsai T; Klausmeyer A; Conrad R; Gottschling C; Leo M; Faissner A; Wiese S
Mol Cell Neurosci; 2013 Sep; 56():18-28. PubMed ID: 23500004
[TBL] [Abstract][Full Text] [Related]
15. Running exercise delays neurodegeneration in amygdala and hippocampus of Alzheimer's disease (APP/PS1) transgenic mice.
Lin TW; Shih YH; Chen SJ; Lien CH; Chang CY; Huang TY; Chen SH; Jen CJ; Kuo YM
Neurobiol Learn Mem; 2015 Feb; 118():189-97. PubMed ID: 25543023
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia.
Yang YJ; Li YK; Wang W; Wan JG; Yu B; Wang MZ; Hu B
Pharmacol Biochem Behav; 2014 Jul; 122():30-6. PubMed ID: 24662915
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
[TBL] [Abstract][Full Text] [Related]
18. Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease.
Wang ZH; Xiang J; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Wu S; Wang JZ; Ye K
Cell Rep; 2019 Jul; 28(3):655-669.e5. PubMed ID: 31315045
[TBL] [Abstract][Full Text] [Related]
19. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
20. 7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice.
Bollen E; Vanmierlo T; Akkerman S; Wouters C; Steinbusch HM; Prickaerts J
Behav Brain Res; 2013 Nov; 257():8-12. PubMed ID: 24070857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
